Nanoparticle-facilitated Functional and Molecular Imaging for the Early Detection of Cancer

Cancer detection in its early stages is imperative for effective cancer treatment and patient survival. In recent years, biomedical imaging techniques, such as magnetic resonance imaging, computed tomography and ultrasound have been greatly developed and have served pivotal roles in clinical cancer...

Full description

Bibliographic Details
Main Authors: Maharajan eSivasubramanian, Yu eHsia, Leu-Wei eLo
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-10-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmolb.2014.00015/full
id doaj-e04e6e2990b5401584f344980c2cdbeb
record_format Article
spelling doaj-e04e6e2990b5401584f344980c2cdbeb2020-11-24T22:40:13ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2014-10-01110.3389/fmolb.2014.00015109909Nanoparticle-facilitated Functional and Molecular Imaging for the Early Detection of CancerMaharajan eSivasubramanian0Yu eHsia1Leu-Wei eLo2National Health Research InstitutesNational Health Research InstitutesNational Health Research InstitutesCancer detection in its early stages is imperative for effective cancer treatment and patient survival. In recent years, biomedical imaging techniques, such as magnetic resonance imaging, computed tomography and ultrasound have been greatly developed and have served pivotal roles in clinical cancer management. Molecular imaging (MI) is a non-invasive imaging technique that monitors biological processes at the cellular and sub-cellular levels. To achieve these goals, MI uses targeted imaging agents that can bind targets of interest with high specificity and report on associated abnormalities, a task that cannot be performed by conventional imaging techniques. In this respect, MI holds great promise as a potential therapeutic tool for the early diagnosis of cancer. Nevertheless, the clinical applications of targeted imaging agents are limited due to their inability to overcome biological barriers inside the body. The use of nanoparticles has made it possible to overcome these limitations. Hence, nanoparticles have been the subject of a great deal of recent studies. Therefore, developing nanoparticle-based imaging agents that can target tumors via active or passive targeting mechanisms is desirable. This review focuses on the applications of various functionalized nanoparticle-based imaging agents used in MI for the early detection of cancer.http://journal.frontiersin.org/Journal/10.3389/fmolb.2014.00015/fullGadoliniumMolecular ImagingnanoparticleQuantum dotsgold nanoparticlesIron oxide nanoparticles
collection DOAJ
language English
format Article
sources DOAJ
author Maharajan eSivasubramanian
Yu eHsia
Leu-Wei eLo
spellingShingle Maharajan eSivasubramanian
Yu eHsia
Leu-Wei eLo
Nanoparticle-facilitated Functional and Molecular Imaging for the Early Detection of Cancer
Frontiers in Molecular Biosciences
Gadolinium
Molecular Imaging
nanoparticle
Quantum dots
gold nanoparticles
Iron oxide nanoparticles
author_facet Maharajan eSivasubramanian
Yu eHsia
Leu-Wei eLo
author_sort Maharajan eSivasubramanian
title Nanoparticle-facilitated Functional and Molecular Imaging for the Early Detection of Cancer
title_short Nanoparticle-facilitated Functional and Molecular Imaging for the Early Detection of Cancer
title_full Nanoparticle-facilitated Functional and Molecular Imaging for the Early Detection of Cancer
title_fullStr Nanoparticle-facilitated Functional and Molecular Imaging for the Early Detection of Cancer
title_full_unstemmed Nanoparticle-facilitated Functional and Molecular Imaging for the Early Detection of Cancer
title_sort nanoparticle-facilitated functional and molecular imaging for the early detection of cancer
publisher Frontiers Media S.A.
series Frontiers in Molecular Biosciences
issn 2296-889X
publishDate 2014-10-01
description Cancer detection in its early stages is imperative for effective cancer treatment and patient survival. In recent years, biomedical imaging techniques, such as magnetic resonance imaging, computed tomography and ultrasound have been greatly developed and have served pivotal roles in clinical cancer management. Molecular imaging (MI) is a non-invasive imaging technique that monitors biological processes at the cellular and sub-cellular levels. To achieve these goals, MI uses targeted imaging agents that can bind targets of interest with high specificity and report on associated abnormalities, a task that cannot be performed by conventional imaging techniques. In this respect, MI holds great promise as a potential therapeutic tool for the early diagnosis of cancer. Nevertheless, the clinical applications of targeted imaging agents are limited due to their inability to overcome biological barriers inside the body. The use of nanoparticles has made it possible to overcome these limitations. Hence, nanoparticles have been the subject of a great deal of recent studies. Therefore, developing nanoparticle-based imaging agents that can target tumors via active or passive targeting mechanisms is desirable. This review focuses on the applications of various functionalized nanoparticle-based imaging agents used in MI for the early detection of cancer.
topic Gadolinium
Molecular Imaging
nanoparticle
Quantum dots
gold nanoparticles
Iron oxide nanoparticles
url http://journal.frontiersin.org/Journal/10.3389/fmolb.2014.00015/full
work_keys_str_mv AT maharajanesivasubramanian nanoparticlefacilitatedfunctionalandmolecularimagingfortheearlydetectionofcancer
AT yuehsia nanoparticlefacilitatedfunctionalandmolecularimagingfortheearlydetectionofcancer
AT leuweielo nanoparticlefacilitatedfunctionalandmolecularimagingfortheearlydetectionofcancer
_version_ 1725705357042384896